Larimar Therapeutics to host investor event on June 29

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. AMZN
10. META

Go back to Larimar Therapeutics to host investor event on June 29

Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia

June 26, 2026 4:05 PM EDT

Webcast on Monday, June 29, 2026, at 7:45 am ET

BALA CYNWYD, Pa., June 26, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that the Company will host an investor event to discuss updates for the Companys nomlabofusp clinical development program including a regulatory update and data from the ongoing long-term open label study for the treatment of Friedreichs ataxia on Monday, June 29, 2026 at 7:45 am ET.

Webcast... More